Abstract
Local neuromodulation of brain functions can be accomplished in many ways: electrical stimulation, local micro-infusion of drugs, implantations of viruses or engineered cells, etc. We have studied targeted encapsulated cell implants delivering active substances locally in Alzheimer patients (AD). AD is associated with early loss of basal forebrain cholinergic neurons (BFCNs) and cognitive dysfunction. BFCNs are dependent on nerve growth factor (NGF). Previously, we have developed an encapsulated cell biodelivery (ECB) platform and utilized it to stimulate BFCNs in two cholinergic target sites (Ch4 [nucl.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.